Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disorders.

Cytotherapy - 1 Mar 2023

Ugalde Laura, Fañanas Sara, Torres Raúl, Quintana-Bustamante Oscar, Río Paula

Abstract excerpt

The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system has revolutionized the gene editing field, making it possible to interrupt, insert or replace a sequence of interest with high precision in the human genome. Its easy design and wide applicability open up a variety of therapeutic alternatives for the treatment of genetic diseases. Indeed, very promising approaches for the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR-Cas Systems
Share to Gene Editing
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Source

Identifiers

PMID: 36610813
DOI: 10.1016/j.jcyt.2022.11.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disorders.PMID 36610813Read ↗

CRISPR to fix bad blood: a new tool in basic and clinical hematologySemantic proximity Read ↗

The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies.Semantic proximity Read ↗

CRISPR RNA-Guided Gene Editing and its Clinical Research Applications in Hematology with Focus on Inherited Germline Predisposition to Hematologic MalignanciesSemantic proximity Read ↗

CRISPR ‐Cas9 technology and its application in haematological disordersSemantic proximity Read ↗

Therapeutic gene editing in haematological disorders with CRISPR /Cas9Semantic proximity Read ↗

The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translationSemantic proximity Read ↗

[Research Progress on Application of CRISPR/Cas Genome Editing Technology in Hematological Diseases -Review].Semantic proximity Read ↗

Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood DisordersSemantic proximity Read ↗

Therapy Development by Genome Editing of Hematopoietic Stem CellsSemantic proximity Read ↗

CRISPR-mediated genome editing and human diseasesSemantic proximity Read ↗

Clinical hematopoietic stem cell-based gene therapySemantic proximity Read ↗

Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential HurdlesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.